
ASPI · NASDAQ
ASP Isotopes Inc.
$2.03 +0.04 (+2.23%)
Company overview
ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company also develops Uranium-235, an isotope of uranium for the carbon-free energy industry. ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.
- Sector
- Basic Materials
- Industry
- Chemicals
- Exchange
- NASDAQ
- Market cap
- $311M
- Employees
- 136
- Headquarters
- Washington, FL
- Website
- aspisotopes.com
- CEO
- Paul Elliot Mann
- Listed
- November 10, 2022
- P/E
- -0.98
- Dividend yield
- 0.00%
Company financials
- Revenue
- $26.9M
- Gross profit
- $4.7M
- Operating income
- -$74.1M
- EBITDA
- -$171M
- Net income
- -$174M
- EPS
- -$2.08
- Total assets
- $588M
- Total debt
- $262M
- Gross margin
- 17.62%
- Net margin
- -644.41%
- Earnings yield
- -102.31%
Showing FY 2025